India
# |
Name |
Return on Equity (ROE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1,348.13%
|
March 31, 2024 | USD 0.14 | 3.84% |
|
India |
|
2 |
200.26%
|
March 31, 2024 | USD 2.49 | -4.71% |
|
India |
|
3 |
59.39%
|
Dec. 31, 2023 | USD 63.68 | 0.49% |
|
India |
|
4 |
44.97%
|
March 31, 2024 | USD 1.29 | 2.70% |
|
India |
|
5 |
37.34%
|
June 30, 2024 | USD 62.04 | 1.67% |
|
India |
|
6 |
33.19%
|
March 31, 2024 | USD 22.79 | -0.22% |
|
India |
|
7 |
32.48%
|
March 31, 2024 | USD 301.67 | 0.10% |
|
India |
|
8 |
27.37%
|
March 31, 2024 | USD 15.99 | 6.29% |
|
India |
|
9 |
25.99%
|
March 31, 2024 | USD 58.97 | 0.20% |
|
India |
|
10 |
25.95%
|
March 31, 2024 | USD 5.24 | 4.23% |
|
India |
|
11 |
24.16%
|
March 31, 2024 | USD 37.68 | -1.96% |
|
India |
|
12 |
23.72%
|
March 31, 2024 | USD 13.53 | 0.96% |
|
India |
|
13 |
23.56%
|
March 31, 2024 | USD 6.91 | -0.24% |
|
India |
|
14 |
23.39%
|
March 31, 2024 | USD 162.79 | 2.84% |
|
India |
|
15 |
23.39%
|
March 31, 2024 | USD 28.13 | 1.29% |
|
India |
|
16 |
22.88%
|
March 31, 2024 | USD 31.06 | 0.59% |
|
India |
|
17 |
22.69%
|
March 31, 2024 | USD 83.39 | -0.45% |
|
India |
|
18 |
20.43%
|
March 31, 2024 | USD 28.07 | -2.08% |
|
India |
|
19 |
20.23%
|
March 31, 2024 | USD 63.18 | 1.69% |
|
India |
|
20 |
19.85%
|
March 31, 2024 | USD 14.03 | 1.84% |
|
India |
|
21 |
19.46%
|
March 31, 2024 | USD 11.18 | 1.69% |
|
India |
|
22 |
19.34%
|
March 31, 2024 | USD 32.88 | -0.93% |
|
India |
|
23 |
18.90%
|
March 31, 2024 | USD 20.33 | 0.95% |
|
India |
|
24 |
18.08%
|
March 31, 2024 | USD 11.93 | 1.62% |
|
India |
|
25 |
17.57%
|
March 31, 2024 | USD 26.86 | 1.04% |
|
India |
|
26 |
17.41%
|
March 31, 2024 | USD 58.36 | 0.18% |
|
India |
|
27 |
17.24%
|
March 31, 2024 | USD 16.41 | -0.51% |
|
India |
|
28 |
16.96%
|
March 31, 2024 | USD 7.02 | 1.27% |
|
India |
|
29 |
16.55%
|
March 31, 2024 | USD 1.15 | 4.92% |
|
India |
|
30 |
16.46%
|
March 31, 2024 | USD 11.98 | -1.00% |
|
India |
|
31 |
15.83%
|
March 31, 2024 | USD 0.86 | -0.30% |
|
India |
|
32 |
15.74%
|
March 31, 2024 | USD 8.26 | 2.40% |
|
India |
|
33 |
15.73%
|
March 31, 2024 | USD 18.97 | -2.38% |
|
India |
|
34 |
15.43%
|
March 31, 2024 | USD 17.05 | 1.44% |
|
India |
|
35 |
15.33%
|
March 31, 2024 | USD 52.31 | 0.35% |
|
India |
|
36 |
15.19%
|
March 31, 2024 | USD 2.78 | 0.16% |
|
India |
|
37 |
15.16%
|
March 31, 2024 | USD 14.15 | 2.83% |
|
India |
|
38 |
15.11%
|
March 31, 2024 | USD 18.79 | 3.33% |
|
India |
|
39 |
15.04%
|
March 31, 2024 | USD 20.10 | 0.21% |
|
India |
|
40 |
14.64%
|
March 31, 2024 | USD 12.16 | 1.55% |
|
India |
|
41 |
14.61%
|
March 31, 2024 | USD 8.30 | 0.52% |
|
India |
|
42 |
14.55%
|
March 31, 2024 | USD 5.42 | -1.21% |
|
India |
|
43 |
13.43%
|
March 31, 2024 | USD 9.20 | 2.64% |
|
India |
|
44 |
13.40%
|
March 31, 2024 | USD 23.98 | 0.71% |
|
India |
|
45 |
13.38%
|
March 31, 2024 | USD 4.67 | -0.69% |
|
India |
|
46 |
13.09%
|
March 31, 2024 | USD 4.91 | 0.19% |
|
India |
|
47 |
12.96%
|
March 31, 2024 | USD 78.50 | -0.28% |
|
India |
|
48 |
12.93%
|
March 31, 2024 | USD 11.16 | -0.07% |
|
India |
|
49 |
12.83%
|
March 31, 2024 | USD 9.86 | 2.71% |
|
India |
|
50 |
12.78%
|
March 31, 2024 | USD 10.61 | 0.92% |
|
India |
The Healthcare company in India with the highest Return on Equity (ROE) is TAKE Solutions Limited (NSE: TAKE.NS) at 1,348.13%.
The Healthcare company in India with the lowest Return on Equity (ROE) is Sun Pharma Advanced Research Company Limited (NSE: SPARC.NS) at -307.91%.
The top 10 Healthcare companies in India by Return on Equity (ROE) are TAKE Solutions Limited, Wanbury Limited, Sanofi India Limited, Ind-Swift Laboratories Limited, Procter & Gamble Health Limited, GlaxoSmithKline Pharmaceuticals Limited, Abbott India Limited, Narayana Hrudayalaya Limited, Bayer CropScience Limited and Indraprastha Medical Corporation Limited.
The bottom 10 Healthcare companies in India by Return on Equity (ROE) are Sun Pharma Advanced Research Company Limited, Solara Active Pharma Sciences Limited, Suven Life Sciences Limited, Bajaj HealthCare Limited, Glenmark Pharmaceuticals Limited, Zota Health Care Limited, Wockhardt Limited, Max India Limited, Mangalam Drugs & Organics Limited and Piramal Enterprises Limited.